Abnormal glucose tolerance and non-esterified fatty acids (NEFAs) as predictors of non-alcoholic steatohepatitis (NASH): Which ash that ignites the NASH [3]

Journal of Clinical Gastroenterology

Volumn 41, Issue 1, 2007, Pages 118-119

  Osman, Meissa M ^a   Osman, Khalid A ^b   Ahmed, Mohamed H ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b QUEEN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLUCOSE; INSULIN;

AUTOPSY; BARIATRIC SURGERY; BODY MASS; CLINICAL FEATURE; CLINICAL RESEARCH; DIABETES MELLITUS; DIABETOGENESIS; DISEASE MARKER; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LETTER; LIVER HISTOLOGY; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; PREDICTION; PRIORITY JOURNAL; RISK FACTOR;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; GLUCOSE TOLERANCE TEST; HUMANS; LIVER CIRRHOSIS; OBESITY; PROGNOSIS; RISK FACTORS;

EID: 33846007303     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000212651.05656.5b     Document Type: Letter

References (10)

1. Ahmed MH, Byrne CD. Non-alcoholic steatohepatitis. In: Byrne CD, Wild S, eds. Metabolic Syndrome. England: Wiley & Sons; 2005:279-303.
2. Marceau P, Biron S, Hould FS, et al. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab. 1999;84:1513-1517.
3. Luyckx FH, Scheen AJ, Desaive C, et al. Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. J Diabetes Metab. 1998;24: 355-361.
4. Haukeland JW, Konopski Z, Linnestad P, et al. Abnormal glucose tolerance is a predictor of steatohepatitis and fibrosis in patients with non-alcoholic fatty liver disease. Scand J Gastroentrol. 2005;40: 1469-1477.
5. Holt HB, Wild SH, Wood PJ, et al. Non-esterified fatty acid concentrations are independently associated with hepatic steatosis in obese subjects. Diabetologia. 2006;49:141-148.
6. Paolisso G, Howard BV. Role of non-esterified fatty acids in the pathogenesis of type 2 diabetes mellitus. Diabet Med. 1998;15:360-366.
7. Bays H, Mandarino L, De Fronzo RA. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:463-478.
8. Pirro M, Mauriege P, Tchernof A, et al. Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Quebec Cardiovascular Study. Atherosclerosis. 2002;160: 377-384.
9. Widjaja A, Morris RJ, Levy JC, et al. Within- and between-subject variation in commonly measured anthropometric and biochemical variables. Clin Chem. 1999;45: 561-566.
10. Ahmed MH. Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology. Scand J Gastroenterol. 2005;40:1260